Webinar Now Available On Demand - Advancing Immuno-oncology: Innovative solutions for adoptive cell therapy
Webinar Now Available On Demand - Advancing Immuno-oncology: Innovative solutions for adoptive cell therapy
The C4T team needed to alleviate bandwidth constraints while accelerating progress on key initiatives.
Time-consuming compliance: Approval flows created operational bottlenecks and delayed access to key supplies.
Limited visibility: Manual reporting made it difficult to access real-time data for strategic decision-making.
Manual supplier setup: Vendor onboarding was slow, diverting resources from critical R&D work.
C4T partnered with Prendio-BioProcure to drive a life science procurement transformation tailored to their needs.
Streamlined workflows: Simplified purchasing and approval steps to reduce delays.
Real-time dashboards and integrations: Delivered full visibility and alignment across internal systems.
Compliance without compromise: Maintained controls and auditability while enabling innovation.
C4T’s new procurement model quickly delivered results—reducing costs, accelerating purchasing, and strengthening control.
$350K+ cost savings achieved, supporting innovation at scale.
$68M+ in spend efficiently managed with minimal operational overhead.
Faster, data-driven decisions enabled through real-time analytics dashboards.
With Prendio-BioProcure managing our specialized needs, we’re able to offload time-consuming tasks and focus on critical priorities like supplier selection, cost negotiations, and training. It enables us to think strategically instead of getting stuck in tactical details.
Gina Kelly
Head of Strategic Sourcing and
Procurement, C4 Therapeutics
C4 Therapeutics (C4T) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives.